{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:34:23Z","timestamp":1790177663726,"version":"4.1.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T00:00:00Z","timestamp":1135036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,20]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>A patient with Waldenstrom\u2019s macroglobulinaemia expresses a high titre IgM antibody in serum that binds both mouse and human dendritic cells (DC) in a B7-DC (PD-L2)-dependent manner. We have reported previously that purified antibody from patient serum activates immature and mature DC in vitro, enhancing the ability of these professional antigen-presenting cells to activate naive T cells, take up antigen, resist a cytokine-depleted environment and secrete immunomodulatory cytokines, such as interkeukin (IL)-6 and tumour necrosis factor (TNF)-\u03b1. Systemic treatment of experimental animals with this antibody induces potent anti-melanoma immunity and modulates protectively the recall response against antigen challenge through the airway in an experimental model of inflammatory airway disease. Here we describe a monoclonal IgM antibody derived from this serum immunoglobulin that recapitulates each of these earlier observations, providing direct evidence that M protein from the Waldenstrom\u2019s patient mediates these potent immunomodulatory effects. Furthermore, cell lines expressing this recombinant form of the human antibody provide the basis for developing this reagent for clinical application.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.02992.x","type":"journal-article","created":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T16:32:25Z","timestamp":1135096345000},"page":"314-321","source":"Crossref","is-referenced-by-count":30,"title":["Immunomodulation using the recombinant monoclonal human B7-DC cross-linking antibody rHIgM12"],"prefix":"10.1093","volume":"143","author":[{"given":"V P","family":"Van Keulen","sequence":"first","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Ciric","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Radhakrishnan","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K L","family":"Heckman","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Mitsunaga","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kita","sequence":"additional","affiliation":[{"name":"Department of Immunology"},{"name":"Division of Allergic Disease and Internal Medicine, Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Immunology"},{"name":"Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L R","family":"Pease","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,12,20]]},"reference":[{"key":"2022010522204652300_b1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1084\/jem.20021466","article-title":"Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells","volume":"196","author":"Nguyen","year":"2002","journal-title":"J Exp Med"},{"key":"2022010522204652300_b2","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.4049\/jimmunol.170.4.1830","article-title":"Naturally occurring human IgM antibody that binds B7-DC and potentiates T-cell stimulation by dendritic cells","volume":"170","author":"Radhakrishnan","year":"2003","journal-title":"J Immunol"},{"key":"2022010522204652300_b3","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/0008-5472.CAN-03-3025","article-title":"Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring anti-tumor immunity","volume":"64","author":"Radhakrishnan","year":"2004","journal-title":"Cancer Res"},{"key":"2022010522204652300_b4","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.173.2.1360","article-title":"Blockade of allergic airway inflammation following systemic treatment with a B7-DC (PD-L2) cross-linking human antibody","volume":"173","author":"Radhakrishnan","year":"2004","journal-title":"J Immunol"},{"key":"2022010522204652300_b5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2005.04.038","article-title":"Dendritic cells activated by cross-linking B7-DC (PD-L2) block inflammatory airway disease","volume":"116","author":"Radhakrishnan","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2022010522204652300_b6","doi-asserted-by":"crossref","first-page":"11438","DOI":"10.1073\/pnas.0501420102","article-title":"B7-DC cross-linking restores antigen uptake and augments APC function by matured dendritic cells","volume":"102","author":"Radhakrishnan","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010522204652300_b7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V97.1.321","article-title":"Clonal evolution in Waldenstrom\u2019s macroglobulinemia highlights functional role of B-cell receptor","volume":"97","author":"Ciric","year":"2001","journal-title":"Blood"},{"key":"2022010522204652300_b8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1096\/fj.01-0994fje","article-title":"Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease","volume":"16","author":"Mitsunaga","year":"2002","journal-title":"FASEB J"},{"key":"2022010522204652300_b9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-1119(89)90359-4","article-title":"Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension","volume":"77","author":"Horton","year":"1989","journal-title":"Gene"},{"key":"2022010522204652300_b10","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.97.12.6820","article-title":"Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis","volume":"97","author":"Warrington","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010522204652300_b11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.10033","article-title":"Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice","volume":"37","author":"Bieber","year":"2002","journal-title":"Glia"},{"key":"2022010522204652300_b12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0952-7915(95)80053-0","article-title":"Natural autoantibodies","volume":"7","author":"Coutinho","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"2022010522204652300_b13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02900358","article-title":"Natural catalytic antibodies","volume":"5","author":"Paul","year":"1996","journal-title":"Mol Biotechnol"},{"key":"2022010522204652300_b14","first-page":"167","article-title":"Structure and function of natural antibodies","volume":"210","author":"Casali","year":"1996","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.02992.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/143\/2\/314\/42075615\/j.1365-2249.2005.02992.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/143\/2\/314\/42075615\/j.1365-2249.2005.02992.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T22:28:39Z","timestamp":1641421719000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/143\/2\/314\/6457885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,20]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,12,20]]},"published-print":{"date-parts":[[2005,12,20]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02992.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,12,20]]}}}